Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells
- PMID: 3023969
- PMCID: PMC367059
- DOI: 10.1128/mcb.6.9.3221-3231.1986
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells
Abstract
Murine bone marrow was either singly or doubly infected with retroviral vectors expressing v-myc (OK10) or v-Ha-ras. The infected bone marrow was cultured in a system that supports the long-term growth of B-lineage lymphoid cells. While the v-myc vector by itself had no apparent effect on lymphoid culture establishment and growth, infection with the v-Ha-ras vector or coinfection with both v-myc and v-Ha-ras vectors led to the appearance of growth-stimulated cell populations. Clonal pre-B-cell lines stably expressing v-Ha-ras alone or both v-myc and v-Ha-ras grew out of these cultures. In comparison with cell lines expressing v-Ha-ras alone, cell lines expressing both v-myc and v-Ha-ras grew to higher densities, had reduced dependence on a feeder layer for growth, and had a marked increase in ability to grow in soft-agar medium. The cell lines expressing both oncogenes were highly tumorigenic in syngeneic animals. These experiments show that the v-myc oncogene in synergy with v-Ha-ras can play a direct role in the in vitro transformation of murine B lymphoid cells.
Similar articles
-
Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.Oncogene Res. 1988 May;2(4):403-9. Oncogene Res. 1988. PMID: 2840624
-
Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).Cancer Res. 1985 Feb;45(2):726-32. Cancer Res. 1985. PMID: 2981612
-
Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.Oncogene. 1993 Aug;8(8):2119-25. Oncogene. 1993. PMID: 8336938
-
Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl.Mol Cell Biol. 1989 Jan;9(1):67-73. doi: 10.1128/mcb.9.1.67-73.1989. Mol Cell Biol. 1989. PMID: 2784537 Free PMC article.
-
Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis.Symp Fundam Cancer Res. 1986;39:45-56. Symp Fundam Cancer Res. 1986. PMID: 3321309 Review.
Cited by
-
Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine.Mol Cell Biol. 1991 Mar;11(3):1590-7. doi: 10.1128/mcb.11.3.1590-1597.1991. Mol Cell Biol. 1991. PMID: 1996110 Free PMC article.
-
Negative autoregulation of c-myc gene expression is inactivated in transformed cells.EMBO J. 1990 Dec;9(12):3913-22. doi: 10.1002/j.1460-2075.1990.tb07612.x. EMBO J. 1990. PMID: 2249657 Free PMC article.
-
The 5' noncoding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation.Mol Cell Biol. 1989 Nov;9(11):5234-8. doi: 10.1128/mcb.9.11.5234-5238.1989. Mol Cell Biol. 1989. PMID: 2601719 Free PMC article.
-
Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.Mol Cell Biol. 1989 May;9(5):1866-74. doi: 10.1128/mcb.9.5.1866-1874.1989. Mol Cell Biol. 1989. PMID: 2747638 Free PMC article.
-
In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.Proc Natl Acad Sci U S A. 1987 Sep;84(18):6558-62. doi: 10.1073/pnas.84.18.6558. Proc Natl Acad Sci U S A. 1987. PMID: 3498165 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials